Earnings Releases·Nov 9, 2026, 4:11 PM ET

Hims & Hers Health, Inc. — Third Quarter 2026 Earnings Summary

Q3 2026 total revenue reached $890.4 million, up 49% year-over-year, driven by a 321% surge in international revenue to $233.3 million, though gross margin contracted to 57% from 74% and the company reported a net loss of $33.0 million versus prior-year net income of $15.8 million.
Full-year 2026 guidance was tightened to revenue of $3.13–$3.15 billion and Adjusted EBITDA of $257–$277 million, with Q4 revenue guidance set at $875–$895 million and Adjusted EBITDA at $70–$90 million.
Strategic capital deployment included $318.1 million in business acquisitions and $390.4 million in convertible senior notes issued during the first nine months, contributing to a rise in total liabilities to $3.19 billion and a decline in free cash flow to $26.0 million for the quarter.
Subscriber count grew 13% year-over-year to nearly 2.8 million, while monthly revenue per subscriber increased 30% to $105, alongside a strategic shift in the US weight loss offering to align with global branded GLP-1 access.